Cytokine gene activity in AML cells in vivo in patients

Leukemia Research

Volumn 22, Issue 5, 1998, Pages 429-438

  Gao, Xue Zhi ^a   Bi, Sucai ^a   Copra, Harpreet ^a   Devemy, Emanuel ^a   Venugopal, Parameswaran ^a   Li, Biarou ^a   Hsu, We Tong ^a   Loew, Jerome ^a   Galvez, Angel ^a   Gregory, Stephanie ^a   Yang, Jie ^a   Horvath, Erzsebet ^a   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

AML; Cytokines; GMCSF; IL1 ; IL1ra; IL6; TNF

Indexed keywords

CYTARABINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOXANTRONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA REMISSION; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW CELLS; CYTOKINES; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION; RNA, MESSENGER; SPECIMEN HANDLING; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032077435     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00024-1     Document Type: Article

References (25)

1. Griffin J.D., Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 68(6):1986;1185.
2. Russell N. Autocrine growth factors and leukemia hematopoiesis. Blood Rev. 6:1992;149.
3. Bradbury D., Rogers S., Kozlowski R., Bowen G., Reilly I.A.G., Russell N.H. Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blasts cells of acute myeloblastic leukaemia. Br J Haematol. 76(4):1990;488.
4. Oster W., Cicco N.A., Klein H.et al. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Cain Invest. 84(2):1989;451.
5. Preisler H.D., Bi S., Venugopal P., Raza A. Cytokines, molecular biologic abnormalities, and acute myelogenous leukemia. Leuk Res. 21:1997;299.
6. Van der Schoot C.E., Jansen P., Porter M., Wester M.R., von dem Borne A.E.G.K., Aarden La Van Oers H.J. Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood. 74(6):1989;2081.
7. Beauchemin L., Villenueuve J.C., Rodriguez-Cimadevilla D., Rajotte J.S., Kenneu S.C., Clark T. Interleukin-6 production by the blasts cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications. J Cell Physiol. 148:1991;352.
8. Preisler H.D., Venugopal P. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment. Leuk Res. 18(3):1994;149.
9. Preisler H.D., Raza A. Current problems in the treatment of acute myelocytic leukemia (AML) and some possible solutions. Leukemia. 6(2):1992;81-88.
10. Kaufman D.C., Baer M.R., Gao X.-Z., Wang Z., Preisler H.D. Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in-vitro blast cell enrichment. Blood. 72:1988;1329.
11. Baer M.R., Watt C.C., Preisler H.D. Expression of the GM-CSF and IL-1 genes in acute myelogenous leukemia cells is induced by in vitro cell processing. Blood. 72(5):1988;109a.
12. Wakamiya N., Stone R., Takeyama H., Spriggs D., Kufe D. Detection of tumor necrosis factor gene expression at a cellular level in human acute myeloid leukemias. Leukemia. 1(3):1989;51.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
14. Lyman S.D., James L., Johnson L.et al. Cloning of the human homologue of the murine flt-3 ligand: a growth factor for early hematopoietic progenitor cells. Blood. 83:1994;2795.
15. Bi S., Hughes T., Bungey J., Chase A., de Fabritis P., Goldman J.M. p53 In chronic myeloid leukemia cell lines. Leukemia. 6:1992;839.
16. Edwards M.C., Gibbs R.A. Multiplex PCR: advantages, development, and applications. PCR Methods Appl. 3(4):1994;S65.
17. Raza A., Preisler H.D., Day R.et al. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics. A Leukemia Intergroup Study. Blood. 76:1990;2191.
18. Kotelnikov V., Cass L., Coon J.S., Spaulding D., Preisler H.D. Accuracy of histone H3 mRNA in situ hybridization for the assessment of cell proliferation in human tissues. Clin Cancer Res. 3:1997;669.
19. Hollander M, Wolf DA. Exact confidence intervals for binomial proportions. In: Hollander, Wolf, editors. Nonparametric Statistical Methods. New York: Wiley, 1973:23.
20. Preisler HD, Li B, Yang J et al. The premyelodysplastic state and the secondary hematologic disorders. Acute Leukemias VII in Munster, Germany. 1997 (in press).
21. Rambaldi A., Torcia M., Bettoni S.et al. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood. 78(12):1991;3248.
22. Yin M., Venugopal P., Banavali S.D., Gartside P., Preisler H.D. Effects of IL-1β receptor antagonist on acute myeloid leukemia cells. Leukemia. 6(9):1992;898.
23. Estrov Z., Kurzrock R., Wetzler M.et al. Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood. 78(6):1991;1476.
24. Karp J.E., Burke P.J. Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation. Cancer Res. 36:1976;3600.
25. Cluitmans F.H.M., Esendam B.H.J., Landegent J.E., Willemze R., Falkenburg J.H.F. Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood. 85:1995;2038.